Search research articles
Contact Us
Filters
Showing results (1-10 of 6) with videos related to
Page
of 1
Sort By:
International Journal of Molecular Sciences
|
February 18, 2017
Chitosan-Recombinamer Layer-by-Layer Coatings for Multifunctional Implants
Jeevan Prasaad Govindharajulu, Xi Chen, Yuping Li, et al.
Cancer Research
|
April 28, 2017
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity
Susan L Holbeck, Richard Camalier, James A Crowell, et al.
Molecular Cancer Therapeutics
|
February 16, 2018
Molecular Pharmacodynamics-Guided Scheduling of Biologically Effective Doses: A Drug Development Paradigm Applied to MET Tyrosine Kinase Inhibitors
Apurva K Srivastava, Melinda G Hollingshead, Jeevan Prasaad Govindharajulu, et al.
Molecular Cancer Therapeutics
|
March 17, 2026
Dynamic switching of apoptosis-modulating BIM heterodimers in response to BH3 mimetics in xenograft models of hematologic malignancies
Jeevan Prasaad Govindharajulu, Sharon Fluss, Melinda G Hollingshead, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
Effect of a Smac Mimetic (TL32711, Birinapant) on the Apoptotic Program and Apoptosis Biomarkers Examined with Validated Multiplex Immunoassays Fit for Clinical Use
Apurva K Srivastava, Soumya Jaganathan, Laurie Stephen, et al.
Nature Medicine
|
January 6, 2025
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial
Andrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 6) with videos related to
Sort By:
Page
of 1
International Journal of Molecular Sciences
|
February 18, 2017
Chitosan-Recombinamer Layer-by-Layer Coatings for Multifunctional Implants
Jeevan Prasaad Govindharajulu, Xi Chen, Yuping Li, et al.
Cancer Research
|
April 28, 2017
The National Cancer Institute ALMANAC: A Comprehensive Screening Resource for the Detection of Anticancer Drug Pairs with Enhanced Therapeutic Activity
Susan L Holbeck, Richard Camalier, James A Crowell, et al.
Molecular Cancer Therapeutics
|
February 16, 2018
Molecular Pharmacodynamics-Guided Scheduling of Biologically Effective Doses: A Drug Development Paradigm Applied to MET Tyrosine Kinase Inhibitors
Apurva K Srivastava, Melinda G Hollingshead, Jeevan Prasaad Govindharajulu, et al.
Molecular Cancer Therapeutics
|
March 17, 2026
Dynamic switching of apoptosis-modulating BIM heterodimers in response to BH3 mimetics in xenograft models of hematologic malignancies
Jeevan Prasaad Govindharajulu, Sharon Fluss, Melinda G Hollingshead, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 9, 2015
Effect of a Smac Mimetic (TL32711, Birinapant) on the Apoptotic Program and Apoptosis Biomarkers Examined with Validated Multiplex Immunoassays Fit for Clinical Use
Apurva K Srivastava, Soumya Jaganathan, Laurie Stephen, et al.
Nature Medicine
|
January 6, 2025
Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial
Andrea M Gross, Geraldine O'Sullivan Coyne, Eva Dombi, et al.
Page
of 1